Holmium-166 Transarterial Radioembolization for the Treatment of Intrahepatic Cholangiocarcinoma: A Case Series.

ABSTRACT:

Background

Transarterial radioembolization (TARE) is used to treat primary and secondary malignancies in the liver that are not amenable to curative resection. Accumulating evidence demonstrates the efficacy and safety of TARE with yttrium-90 (⁹⁰Y), which is the most widely used radionuclide for TARE, and later with holmium-166 (¹⁶⁶Ho) for various indications. However, the safety and efficacy of ¹⁶⁶Ho TARE in patients with intrahepatic cholangiocarcinoma (ICC) remains to be studied.

Methods

This was a retrospective case series study of seven consecutive patients with ICC who were treated with ^166-Ho-TARE in our center. We recorded the clinical parameters and outcomes of the TARE procedures, the tumor response according to mRECIST,

SUBMITTER: Vermeulen S 

PROVIDER: S-EPMC10571855 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature